Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03797638
Other study ID # SSA_2018_4
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date July 19, 2019

Study information

Verified date June 2021
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Writer's cramp is a focal dystonia characterized by abnormal movements and postures during writing. Limited finger independence during writing manifests as difficulty suppressing unwanted activations of neighbouring non task-relevant fingers. Patients with Writer's cramp also have difficulty in fine control of grip force. The investigators have recently developed the Finger Force Manipulandum which quantifies the forces applied by each fingers in different tasks. This method is sensitive for detection and quantification of small unwanted contractions in non-active ('stationary') fingers. Different tasks have been developed to assess abilities such as finger individuation but also fine finger force control, finger movement regularity and speed. The aim of this study is to assess if developed tasks allow to precisely characterize writer's cramp condition in terms of abilities aforementioned. To do so, performance of 20 writer's cramp patients in the developed task will be compared with performance of 20 control participants (matched in age, sex and writing hand) in the same tasks.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 19, 2019
Est. primary completion date July 19, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria for patients with writer's cramp - Patient with writer's cramp and writing speed <140 letters / min - Writer's cramp focal dystonia specific to the task of writing - Patient treated or not with botulinum toxin injection - Person having attended school in French Non inclusion criteria for patients with writer's cramp - Patients whose writer's cramp has no impact on the handwriting and has kept a writing speed> 140 letters per minute. - Tremor of writing - Neurological condition other than writer's cramp (eg Parkinson's syndrome) - Pain, trauma or pathology of the upper limb of the writing member other than the writer's cramp who required medical or surgical treatment in the last 6 months preceding the initial check-up Inclusion criteria for control subjects •> 18 years old - Without writer's cramp - Person having attended school in French Non inclusion criteria for control subjects - Tremor of writing - Neurological condition other than writer's cramp (eg Parkinson's syndrome) - Pain, trauma or pathology of the upper limb of the writing member other than the writer's cramp who required medical or surgical treatment in the last 6 months preceding the initial check-up Matching criteria between cases and control patients - Age (± 5 years) - Gender - Hand writing

Study Design


Intervention

Device:
Finger Force Manipuladum (FFM)
Tasks performed with the device Finger Force Manipuladum (FFM), to assess abilities such as finger individuation but also fine finger force control, finger movement regularity and speed.

Locations

Country Name City State
France Fondation A de Rothschild Paris

Sponsors (2)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild Institut National de la Santé Et de la Recherche Médicale, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Manual dexterity by the FFM Compare the manual dexterity by the FFM between subjects with writer's cramp and control subject Inclusion
See also
  Status Clinical Trial Phase
Completed NCT04692285 - Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia Phase 1
Completed NCT00505323 - Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness Phase 1
Terminated NCT03206112 - Loss of Depotentiation in Focal Dystonia
Completed NCT00025701 - EEG and EMG Studies of Hand Dystonia N/A
Completed NCT02334683 - Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia N/A
Terminated NCT01750346 - Acetyl Hexapeptide-8 for Blepharospasm Phase 2
Completed NCT01738581 - rTMS and Retraining in Focal Hand Dystonia Phase 1/Phase 2
Terminated NCT02106936 - Depotentiation in People With Focal Hand Dystonia N/A
Completed NCT00310414 - fMRI Studies of Task Specificity in Focal Hand Dystonia N/A
Completed NCT00309010 - Neurophysiology of Task-Specificity of Focal Hand Dystonia N/A
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Completed NCT00306865 - Brain Changes in Patients With Focal Hand Dystonia N/A
Completed NCT00411255 - Brain Stimulation to Treat Blepharospasm or Meige Syndrome Phase 2
Terminated NCT00487383 - Brain Changes in Blepharospasm
Recruiting NCT05095740 - Effects of Neuromodulation in Laryngeal Dystonia N/A
Completed NCT00713414 - Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
Completed NCT00942851 - A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm Phase 1/Phase 2
Completed NCT00118586 - Neuropathology of Spasmodic Dysphonia
Completed NCT02326818 - Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity Phase 3
Active, not recruiting NCT02911103 - Deep Brain Stimulation Surgery for Focal Hand Dystonia Phase 1/Phase 2